Compare ALAR & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALAR | NMTC |
|---|---|---|
| Founded | 2013 | 2009 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.7M | 39.5M |
| IPO Year | 2018 | 2010 |
| Metric | ALAR | NMTC |
|---|---|---|
| Price | $6.96 | $4.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $14.00 | $11.90 |
| AVG Volume (30 Days) | 29.8K | ★ 182.5K |
| Earning Date | 05-28-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 80.43 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,097,692.00 |
| Revenue This Year | $24.51 | N/A |
| Revenue Next Year | $33.43 | $31.90 |
| P/E Ratio | $44.31 | ★ N/A |
| Revenue Growth | N/A | ★ 163.47 |
| 52 Week Low | $5.50 | $0.55 |
| 52 Week High | $18.00 | $5.40 |
| Indicator | ALAR | NMTC |
|---|---|---|
| Relative Strength Index (RSI) | 55.23 | 86.80 |
| Support Level | $6.34 | $0.69 |
| Resistance Level | $7.76 | N/A |
| Average True Range (ATR) | 0.46 | 0.24 |
| MACD | 0.11 | 0.38 |
| Stochastic Oscillator | 65.10 | 86.33 |
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment: web data collection. Geographically, it derives maximum revenue from China, followed by the United States, Europe, Hong Kong, Asia-Pacific, U.K. Virgin Islands, Israel, United Arab Emirates, Middle East & Africa and other.
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.